Sunshine Biopharma Inks $4M At-The-Market Sales Agreement With Aegis Capital

Benzinga Newsdesk www.benzinga.com Neutral 91.7%

Neg 0% Neu 91.7% Pos 0%

https://www.sec.gov/ix?doc=/Archives/edgar/data/1402328/000168316826005656/sunshine_8k.htm

Comments

No comments yet. Be the first!